All News

Watch Dr. Barbara Ma, from Weill Cornell Medicine, discuss the basics of basal and squamous cell carcinomas during the CURE Educated Patient Skin Cancer Summit.

There are many people in my life who made my cancer experience far easier. I call them my "cancer posse."

Long-term clinical trial data showed that the use of Copiktra was associated with an increased rate of death and severe side effects for patients with chronic lymphocytic leukemia and small cell leukemia.

While my wife has been an amazing caregiver throughout my cancer experience, I realized that it was not fair for her to continually be on the receiving end of all my negative emotions.

Social support and maintaining a positive attitude are crucial when facing a diagnosis of a myeloproliferative neoplasm, according to a caregiver and health care provider.

Watch Emily Huskey, Dr. Wendy Baer, Fabienne Ehivet and Lisa Weems answer questions about areas outside of treatment during the CURE Educated Patient Metastatic Breast Cancer Summit.

She has helped me so much with my medications, and she always lifts me up when I need it most.

Watch Fabienne Ehivet, from Emory Saint Joseph’s Hospital, discuss genetic testing, during the CURE Educated Patient Metastatic Breast Cancer Summit.

This past year amid the COVID-19 pandemic has highlighted just how extraordinary and wonderful Anne Draxl, B.S.N., RN, is for our practice.

Watch Dr. Wendy Baer, from Winship Cancer Institute at Emory University, discuss psychosocial issues, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Backed by her personal cancer experience, an oncology nurse became a volunteer with the Bladder Cancer Advocacy Network.

Watch Emily Huskey, from the Winship Cancer Institute of Emory University, discuss diet and exercise, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Treatment with Gen-1, a novel gene therapy, resulted in a 33% improvement in progression-free survival for patients with advanced ovarian cancer, according to recent study findings.

As I reflect on the month of June, I see it as my “rebirth,” as four years ago, I was diagnosed with cancer, and my life has not been the same ever since.

From “General Hospital” star Cameron Mathison discussing his cancer experience to Dame Deborah James and Hells Angels founder Sonny Barger dying of the disease, here’s what happened in the cancer space this week.

Watch Dr. Kimberly Curseen, Dr. Anna Bausum, Dr. Kevin Kalinsky and Alyncia Mason answer questions about additional care, during the CURE Educated Patient Metastatic Breast Cancer Summit.

The study the FDA allowed to continue is investigating the safety and efficacy of the novel cancer drug ACR-368 in patients with endometrial, urothelial and ovarian cancer.

Culturally specific resources are needed to help fight against the stigmas Asian American cancer survivors and patients face, according to a group of experts.

When I noticed the bare shelves in a recent trip to the grocery store, I started to think about how supply chain issues might impact cancer care.

In less than a year, Christine Whelchel went from receiving a diagnosis of breast cancer to becoming a trailblazing “Jeopardy!” champion.

Watch Dr. Kevin Kalinsky, from Winship Cancer Institute of Emory University, discuss joining clinical trials, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Here is a roundup of cancer treatments that were approved by the FDA in the spring of 2022 that patients may have missed.

After seven years, my prosthetic breast, “Rightie,” sprung a leak and needed to be replaced.

Findings from several studies have shown that childhood cancer survivors often stop attending much needed follow-up visits in the years following treatment.

Watch Dr. Anna Bausum, Winship Cancer Institute at Emroy University, discuss alternative medicine, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Spring 2022 brought in some landmark blood cancer approvals from the FDA. Here is a roundup of the therapies recently approved by the FDA that patients may have missed.

When participating in FORCE’s Virtual Advocacy Day, it was difficult for me not to go off-script, as anger welled up inside me.

The FDA plans to accelerate its review of IK-930, an investigational drug, for the treatment of patients with unresectable NF2-deficient malignant pleural mesothelioma, a rare cancer.

Watch Dr. Kimberly Curseen, from Winship Cancer Institute of Emory University, discuss supportive care, during the CURE Educated Patient Metastatic Breast Cancer Summit.